Medical Portal

The British biotechnological company Intercytex which has developed an artificial skin, has declared successful end of clinical tests early phase. The piece of a skin called ICX-SKN, transplanted to healthy volunteers, has provided healing of small wounds within 28 days.
ICX-SKN is created on the basis of fibrin (albumen of blood coagulative systems) and fibroblasts (the cells included in a skin of a person). At connection of these components cells start to develop collagen - the albumen which makes the fibrous basis steadier. This process reproduces the natural process of wounds healing in an organism of the person. In such stable form the artificial skin is implanted into an area of damage.
6 healthy volunteers have taken part in ICX-SKN’s testing. The piece of an artificial skin created in laboratory was placed on the shoulder by means of special sterile bands.
After four weeks bandages were removed. For this time wounds have completely skinned over with small scars, informed the head of research Paul Kemp. As he said, the subsequent laboratory research revealed no essential differences between samples of a “old” and “new” skin.